10|2025
NeuroStar TMS for Teens With Major Depressive Disorder: Exploring the Latest Findings
Main Findings from the Data Presented at the 2024 AACAP Annual Conference on NeuroStar® TMS for Adolescents: 1. High Remission and Response Rates: – Nearly 60% of adolescents aged 12-19 with Major Depressive Disorder (MDD) achieved remission after treatment with NeuroStar Advanced TMS. – The remission rate for young adults aged 20-21 was… Read more »
